3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Carcinoma, Non-Small-Cell Lung
26
Small Cell Lung Carcinoma
10
Sarcoma
8
Breast Neoplasms
8
Carcinoma, Hepatocellular
7
Lung Neoplasms
6
Stomach Neoplasms
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma
4
Non-squamous Non-small Cell Lung Cancer
3
NSCLC
3
Glioma
3
Uterine Cervical Neoplasms
2
Urogenital Neoplasms
2
Thyroid Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Neoplasms
2
Liver Neoplasms
2
Gynecological Cancer
2
Extensive Stage Small Cell Lung Cancer
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Digestive System Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Advanced Solid Tumor
2
Squamous Non-small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Carboplatin
15
Paclitaxel
13
Hyperthermic Intraperitoneal Chemotherapy
6
Cisplatin
5
olaparib
4
niraparib
4
Bevacizumab
4
oregovomab
3
Topotecan
3
Immunohistochemistry
3
Gemcitabine
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
Amplified Fragment Length Polymorphism Analysis
3
pembrolizumab
2
liposomal doxorubicin
2
anlotinib
2
ST 1481
2
Radiotherapy
2
Polymerase Chain Reaction
2
Oxaliplatin
2
Neoadjuvant Therapy
2
Gene Expression Profiling
2
Fluorouracil
2
Flow Cytometry
2
Diathermy
2
Cytoreduction Surgical Procedures
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Ovarian Epithelial
×
anlotinib
×
Clear all
NCT05385068
2022-05-23
t
Peking Union Medical College Hospital
Phase 2
Unknown
35 enrolled
NCT04566952
2020-10-30
ANLOLA
Jiangsu Cancer Institute & Hospital
Phase 2
Unknown
68 enrolled